Esketamine is approved in Europe for treating resistant major depressive disorder
Mahase, E. (2019). Esketamine is approved in Europe for treating resistant major depressive disorder., 10.1136/bmj.l7069
Link to full text
Mahase, E. (2019). Esketamine is approved in Europe for treating resistant major depressive disorder., 10.1136/bmj.l7069
Link to full text